BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17565198)

  • 1. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
    Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
    Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
    [No Abstract]   [Full Text] [Related]  

  • 2. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 3. Rate, degree, and predictors of recovery from disability following ischemic stroke.
    Hankey GJ; Spiesser J; Hakimi Z; Bego G; Carita P; Gabriel S
    Neurology; 2007 May; 68(19):1583-7. PubMed ID: 17485645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early ischemic lesion recurrence within a week after acute ischemic stroke.
    Kang DW; Latour LL; Chalela JA; Dambrosia J; Warach S
    Ann Neurol; 2003 Jul; 54(1):66-74. PubMed ID: 12838521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic atherosclerotic disease and stroke.
    Kronzon I; Tunick PA
    Circulation; 2006 Jul; 114(1):63-75. PubMed ID: 16818829
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
    Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
    Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 10. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
    Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
    Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASA or low-molecular-weight heparin in the initial management of acute ischemic stroke complicating atrial fibrillation?
    Farquhar D
    CMAJ; 2001 Feb; 164(3):396. PubMed ID: 11232150
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of acute ischaemic stroke.
    Al Mahdy H
    Br J Hosp Med (Lond); 2009 Oct; 70(10):572-7. PubMed ID: 19966702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
    Telman G; Kouperberg E; Sprecher E; Yarnitsky D
    J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of acute ischemic stroke].
    Csiba L
    Orv Hetil; 2004 Nov; 145(45):2297-301. PubMed ID: 15573895
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do all young ischemic stroke patients need long-term secondary preventive medication?
    Naess H; Waje-Andreassen U; Thomassen L; Nyland H; Myhr KM
    Neurology; 2005 Aug; 65(4):609-11. PubMed ID: 16116127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin enhancement of collateralization in acute stroke.
    Ovbiagele B; Saver JL; Starkman S; Kim D; Ali LK; Jahan R; Duckwiler GR; Viñuela F; Pineda S; Liebeskind DS
    Neurology; 2007 Jun; 68(24):2129-31. PubMed ID: 17562834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
    Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
    Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.